Placeholder Banner

BIO Statement on U.S.-China Comprehensive Economic Dialogue

May 12, 2017

“The Biotechnology Innovation Organization welcomes news of the U.S.-China agreement on initial results of the 100-day Action Plan of the U.S.-China Comprehensive Economic Dialogue,” said Joseph Damond, Executive Vice President for International Affairs.  “The agreement marks an important first step in the 100-day plan and towards broader engagement through the newly formed U.S.-China Comprehensive Economic Dialogue.” 

“Considering the history of this issue, the ultimate test of success will be for China to follow its process and quickly approve the eight pending biotechnology applications and establish a synchronized, timely and predictable process going forward,” added Damond.  “BIO will continue to engage through this process to monitor the implementation of the agreement.”  

Discover More
20,000+ biotech leaders gather with a shared mission: to improve lives  SAN DIEGO (June 22, 2026) - The BIO International Convention (BIO 2026), the world’s largest and most comprehensive event for the biotechnology industry, begins today…
Patrick J. Plues, Senior Vice President of State Government Affairs & Affiliate Relations at the Biotechnology Innovation Organization (BIO) released the following statement on the veto of Prescription Drug Affordability Boards (PDAB)…
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the resignation of FDA Commissioner Marty Makary.“Dr. Makary inherited an FDA in crisis after the DOGE…